Induction Therapy With Gefitinib Followed by Chemotherapy With Docetaxel and Cisplatin and Intercalated Gefitinib in NSCLC Stages II-IIIB With Activating EGFR Mutation - A Single Arm Phase II Trial
Phase of Trial: Phase II/III
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms NeoIntercal
- 16 Aug 2017 Status changed from recruiting to discontinued.
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.